Transport of Extracellular Vesicles across the Blood-Brain Barrier: Brain Pharmacokinetics and Effects of Inflammation
Open accessThe DOI matches its Crossref record; 56 of the 57 references it cites were found in a registry or an index.
Abstract
Extracellular vesicles can cross the blood–brain barrier (BBB), but little is known about passage. Here, we used multiple-time regression analysis to examine the ability of 10 exosome populations derived from mouse, human, cancerous, and non-cancerous cell lines to cross the BBB. All crossed the BBB, but rates varied over 10-fold. Lipopolysaccharide (LPS), an activator of the innate immune system, enhanced uptake independently of BBB disruption for six exosomes and decreased uptake for one. Wheatgerm agglutinin (WGA) modulated transport of five exosome populations, suggesting passage by adsorptive transcytosis. Mannose 6-phosphate inhibited uptake of J774A.1, demonstrating that its BBB transporter is the mannose 6-phosphate receptor. Uptake rates, patterns, and effects of LPS or WGA were not predicted by exosome source (mouse vs. human) or cancer status of the cell lines. The cell surface proteins CD46, AVβ6, AVβ3, and ICAM-1 were variably expressed but not predictive of transport rate nor responses to LPS or WGA. A brain-to-blood efflux mechanism variably affected CNS retention and explains how CNS-derived exosomes enter blood. In summary, all exosomes tested here readily crossed the BBB, but at varying rates and by a variety of vesicular-mediated mechanisms involving specific transporters, adsorptive transcytosis, and a brain-to-blood efflux system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 On-bead flow cytometry of exosome populations isolated from supernatants of 4 different cell lines, captured on streptavidin beads coated with biotinylated anti-CD63 mAbs and stained with the labeled detection Abs specific for CD46, αVβ6, αVβ3 and ICAM1 as described in Methods. Data are relative fluorescence intensity (RFI) values calculated as mean fluorescence intensity (MFI) of an experimental sample/MFI of an isotype control Ab. [White peaks = experimental samples; hatched peaks = isotope controls]. Note that exosomes produced by non-malignant cells (HaCaT and primary T cells) appear to differ from exosomes produced by malignant cells by the absence of αVβ3 and lower expression levels of αVβ6. Representative results are from 1 to 3 detection experiments performed with each exosome population.](https://figures.cochat.ai/paper-figures/624d7ee716904379955ce30fbf39b5dc/transport-of-extracellular-vesicles-across-the-blood-brain-barrier-brain-figure-2.jpg)






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, EVs have inherent targeting capabilities and can cross the BBB, facilitating efficient delivery of therapeutic cargo to the CNS [54–57].”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [57]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Brain-derived EVs have been found to harbor the ability to penetrate the BBB. This breakdown is crucial as it potentially allows for releasing these EVs into peripheral circulation [54–57].”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [57]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“sEVs can cross the blood–brain barrier and deliver cargo with crucial roles in many neurological disorders [17–23].”
From Differential RNA packaging into small extracellular vesicles by neurons and astrocytes (2021) · cites this paper as [21]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Théry, C., Witwer, K. W., Aikawa, E., Alcaraz, M. J., Anderson, J. D., Andriantsitohaina, R., Antoniou, A., Arab, T., Archer, F., Atkin‐Smith, G. K., et al. (2018) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2018.1535750 · Cited by 11,099 · cited 3×
“EVs we refer to as “exosomes” were isolated by mini-size exclusion chromatography (SEC) from supernatants of 10 different human or murine cell lines (Table 1) and characterized according to the Minimal Information for Studies of Extracellular Vesicles 2018 (MISEV2018) criteria [2], as is routinely done in our laborato…”
BackgroundMethodShedding light on the cell biology of extracellular vesicles
van Niel, G., D'Angelo, G., & Raposo, G. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.125 · Cited by 8,369 · cited 2×
“of parent cells, where they are formed by inverse membrane invagination as intraluminal vesicles inside multivesicular bodies (MVBs) [4].”
BackgroundExtracellular vesicles: Exosomes, microvesicles, and friends
Raposo, G., & Stoorvogel, W. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201211138 · Cited by 8,099 · cited 1×
“Exosomes are a subset of small extracellular vesicles (EVs) that are produced by all normal and malignant cells and are present in all body fluids [1].”
BackgroundGraphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data
Patlak, C. S., Blasberg, R. G., & Fenstermacher, J. D. (1983) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1983.1 · Cited by 3,567
Exosomes as drug delivery vehicles for Parkinson’s disease therapy
Haney, M. J., Klyachko, N. L., Zhao, Y., Gupta, R., Plotnikova, E. G., He, Z., Patel, T., Piroyan, A., Sokolsky, M., Kabanov, A. V., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.03.033 · Cited by 2,009 · cited 1×
“, drug-loaded exosomes enter the brain using the same mechanisms as those employed by the parent cells [12].”
BackgroundAbels, E. R., & Breakefield, X. O. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-016-0366-z · Cited by 1,678 · cited 1×
“Among the various EVs, exosomes are sized at 30–150 nm in diameter and are of special interest because of their origin, their ability to freely circulate and infiltrate various tissues and their molecular content mirroring that of parental cells [3].”
BackgroundZhang, H., Freitas, D., Kim, H. S., Fabijanic, K., Li, Z., Chen, H., Mark, M. T., Molina, H., Martin, A. B., Bojmar, L., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0040-4 · Cited by 1,613 · cited 1×
“The orientation of surface proteins in exosome membranes resembles that in the cell membrane of parent cells [5].”
BackgroundExtracellular Vesicles: Unique Intercellular Delivery Vehicles
Maas, S. L. N., Breakefield, X. O., & Weaver, A. M. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.11.003 · Cited by 1,429 · cited 2×
“Exosomes serve as an intercellular communication system, shuttling messages between cells and also conveying peptides, proteins, and genetic materials from parental to recipient cells [6].”
BackgroundFrom blood–brain barrier to blood–brain interface: new opportunities for CNS drug delivery
Banks, W. A. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.21 · Cited by 1,204
Self-citationPlasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease
Shi, M., Liu, C., Cook, T. J., Bullock, K. M., Zhao, Y., Ginghina, C., Li, Y., Aro, P., Dator, R., He, C., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1314-y · Cited by 676
Self-citation
Research works printed but not linked: 1
- Nicolini, M., and Zatta, P.F. (1994). Glycoconjugates and anionic sites in the blood-brain barrier. Glycobiology and the Brain, Pergamon Press.
Cited by
Items 201–300 of 569
Exosome Mediated Cell-Cell Crosstalk in Tissue Injury and Repair
Yadav, A., Nandy, A., Sharma, A., & Ghatak, S. (2024) · Results and problems in cell differentiation · doi:10.1007/978-3-031-62036-2_12 · Cited by 28
Chu, L., Sun, Y., Zhao, Y., Wang, A., Sun, Y., Duan, X., Li, N., Xia, H., Liu, W., & Sun, K. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124262 · Cited by 20
Duarte‐Sanmiguel, S., Panic, A., Dodd, D. J., Salazar‐Puerta, A. I., Moore, J. T., Lawrence, W. R., Nairon, K. G., Francis, C., Zachariah, N., McCoy, W., et al. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202101619 · Cited by 20
Carpenter, M. A., Ginugu, M., Khan, S., & Kemp, M. G. (2022) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2022.04.030 · Cited by 22
Mehryab, F., Taghizadeh, F., Goshtasbi, N., Merati, F., Rabbani, S., & Haeri, A. (2023) · Biochimie · doi:10.1016/j.biochi.2023.05.010 · Cited by 21
Al-Jipouri, A., Eritja, À., & Božić, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010485 · Cited by 24
News about the Role of Fluid and Imaging Biomarkers in Neurodegenerative Diseases
Meldolesi, J. (2021) · Biomedicines · doi:10.3390/biomedicines9030252 · Cited by 23
“EVs have been shown to traffic through the blood–brain barrier [12,13] (step 3 in Figure”
BackgroundInfluentialGaggi, G., Credico, A. D., Izzicupo, P., Iannetti, G., Baldassarre, A. D., & Ghinassi, B. (2021) · Biomedicines · doi:10.3390/biomedicines9070754 · Cited by 22
Emerging Potential of Exosomal Non-coding RNA in Parkinson’s Disease: A Review
Zhang, P., Rasheed, M., Liang, J., Wang, C., Feng, L. P., & Chen, Z. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.819836 · Cited by 25
Choroid plexus-derived extracellular vesicles exhibit brain targeting characteristics
Pauwels, M. J., Xie, J., Ceroi, A., Balusu, S., Castelein, J., Wonterghem, E. V., Imschoot, G. V., Ward, A., Menheniott, T. R., Gustafsson, O., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121830 · Cited by 20
Noori, L., Filip, K., Nazmara, Z., Mahakizadeh, S., Hassanzadeh, G., Bavisotto, C. C., Bucchieri, F., Marino, A., Cappello, F., Wnuk, M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24020927 · Cited by 20
“Consequently, CNS-derived EVs can be obtained from systematic circulation and considered as potential biomarkers of CNS disorders and their progression [71].”
Tam, S., Wear, D., Morrone, C. D., & Yu, W. H. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16108 · Cited by 21
A promising therapeutic: Exosome-mediated mitochondrial transplantation
Cao, M., Zou, J., Shi, M., Zhao, D., Liu, C., Liu, Y., Li, L., & Jiang, H. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113104 · Cited by 20
Characteristics, Classification, and Application of Stem Cells Derived from Human Teeth
Lei, T., Zhang, X., & Du, H. (2021) · Stem Cells International · doi:10.1155/2021/8886854 · Cited by 21
“EVs, including RNA, protein, and lipid metabolites, are able to circulate in the blood and cross the blood-brain barrier [135, 136].”
BackgroundMilk exosomes and a new way of communication between mother and child
Papakonstantinou, E., Dragoumani, K., Mitsis, Τ., Chrousos, G. P., & Vlachakis, D. (2024) · EMBnet journal · doi:10.14806/ej.29.0.1050 · Cited by 17
“Given that EVs have the ability to cross the blood-brain-barrier (Banks et al., 2020), if such exosomes exist, they could -via their cargo-inform the CNS of the health status of every cell type in the body.”
BackgroundCouto, P. S., Stibbs, D. J., Sanchez, B. C., Khalife, R., Panagopoulou, T. I., Barnes, B., George, V., Taghizadeh, R. R., & Rafiq, Q. A. (2024) · Cytotherapy · doi:10.1016/j.jcyt.2024.06.011 · Cited by 20
“This makes them attractive as drug carriers with the potential to target the brain, given their ability to transverse the blood-brain barrier [7,8].”
Lerussi, G., Villagrasa-Araya, V., Moltó‐Abad, M., del Toro, M., Pintos‐Morell, G., Seras‐Franzoso, J., & Abasolo, I. (2025) · Life · doi:10.3390/life15010070 · Cited by 22
“The receptors associated with EV uptake and BBB crossing through this pathway include ICAM-1, CD46, or akin [129].”
Exosome-mediated miRNA delivery: a molecular switch for reshaping neuropathic pain therapy
Wei, Z., Guo, C., Zhou, H., Wu, Y., Zhou, X., Chen, J., & Li, F. (2025) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2025.1625943 · Cited by 31
“Exosomes can traverse the BBB bidirectionally between bloodstream and brain, though specific mechanisms for peripheral-to-brain migration remain incompletely elucidated (Banks et al., 2020).”
Isolation of sensory hair cell specific exosomes in human perilymph
Zhuang, P., Phung, S., Warnecke, A., Arambula, A. M., Peter, M. S., He, M., & Staecker, H. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136282 · Cited by 16
Extracellular vesicles and their microRNA cargo in ischaemic stroke
Fullerton, J. L., Cosgrove, C. C., Rooney, R. A., & Work, L. M. (2022) · The Journal of Physiology · doi:10.1113/jp282050 · Cited by 21
“Additionally, inflammation, such as that in stroke, breaks down the BBB and therefore increases its permeability, which may further enhance these transport processes (Banks et al., 2020).”
BackgroundNeuro‐HIV —New insights into pathogenesis and emerging therapeutic targets
Sviridov, D., & Bukrinsky, M. (2023) · The FASEB Journal · doi:10.1096/fj.202301239rr · Cited by 19
D’Ambrosio, A., Zamboni, S., Camerini, S., Casella, M., Sanchez, M., Pietraforte, D., Vanacore, N., Diociauti, M., Altieri, M., Piero, V. D., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03148-x · Cited by 19
“Although growing evidence showed that small EV can cross BBB in bidirectional way under physiological and pathological conditions [13, 30], we found also large EVs, carrying the major CNS proteins associated with relapse phase, in periphery, suggesting their ability to cross altered BBB during…”
BackgroundMohak, S., & Fábián, Z. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17050641 · Cited by 19
“Surface modifications can enhance their therapeutic potential by improving delivery efficiency via enhanced targeting and, thus, reduced circulation time [132].”
Extracellular vesicle-associated cytokines in sport-related concussion
Meier, T. B., Guedes, V. A., Smith, E. G., Sass, D., Mithani, S., Vorn, R., Savitz, J. B., Teague, T. K., McCrea, M., & Gill, J. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.11.015 · Cited by 16
Jafarinia, M., Farrokhi, M. R., Ganjalıkhani-Hakemi, M., & Cho, W. C. S. (2022) · Human Cell · doi:10.1007/s13577-022-00813-2 · Cited by 16
Palacio, P. L., Pleet, M. L., Reátegui, E., & Magaña, S. M. (2023) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2023.578064 · Cited by 19
Cardenas, H. L., Evanoff, N. G., Fandl, H. K., Berry, A. R., Wegerson, K. N., Ostrander, E. I., Greiner, J. J., Dufresne, S. R., Kotlyar, M., Dengel, D. R., et al. (2023) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00243.2023 · Cited by 18
Abdelmohsen, K., Herman, A. B., Carr, A. E., Henry-Smith, C., Rossi, M. S., Meng, Q., Yang, J., Tsitsipatis, D., Bangura, A., Munk, R. B., et al. (2023) · Journal of Extracellular Biology · doi:10.1002/jex2.106 · Cited by 20
“It is noteworthy that we focused on this size range of sEVPs as these can cross the blood-brain barrier (Banks et al., 2020; Ramos-Zaldivar et al., 2022), and are therefore likely capable of traveling from various tissues to the bloodstream.”
Bir, A., Ghosh, A., Chauhan, A., Saha, S., Saini, A. K., Bisaglia, M., & Chakrabarti, S. (2024) · Antioxidants · doi:10.3390/antiox13030316 · Cited by 20
“Exosomes influence the whole brain, whereas sequestration impacts brain endothelial cells, leading to controlled and particular transport processes [109–111].”
Chu, L., Sun, Y., Tang, X., Duan, X., Zhao, Y., Xia, H., Xu, L., Zhang, P., Sun, K., Yang, G., et al. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c01227 · Cited by 20
Schenck, J. K., Karl, M. T., Paredes, C. C., Bastin, A., Pushkarsky, T., Břicháček, B., Miller, R. H., & Bukrinsky, M. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03124-5 · Cited by 17
“Furthermore, circulating Nef EVs [43] represent another potential source of Nef in the brain, as these vesicles possess the capability to traverse the blood–brain barrier [102].”
BackgroundFigueroa‐Hall, L. K., Burrows, K., Alarbi, A. M., Hannafon, B. N., Hladik, C., Tan, C., Ramesh, R., Stewart, J. L., Risbrough, V. B., Paulus, M. P., et al. (2025) · Journal of Extracellular Biology · doi:10.1002/jex2.70035 · Cited by 18
Stem Cell-Derived Extracellular Vesicles in Skin Antiaging Treatments
Park, J. Y., Jung, S. Y., Yoo, D., Lee, S., Go, D., Bui, V. D., Jung, W., You, D. G., Park, J. H., & Um, W. (2025) · ACS Nano · doi:10.1021/acsnano.4c17406 · Cited by 18
Chen, P., Wang, F., Ling, B., Zhu, Y., Lin, H., Huang, J., & Wang, X.-L. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s526945 · Cited by 19
Exosomes in Age-Related Cognitive Decline: Mechanistic Insights and Improving Outcomes
Duggan, M. R., Lu, A., Foster, T. C., Wimmer, M. E., & Parikh, V. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.834775 · Cited by 16
“The capacity to identify a given exosome’s parent cell is particularly valuable given that peripheral exosomes can penetrate the blood-brain-barrier (BBB), while brain derived exosomes can be readily detected in systemic samples (AlvarezErviti et al., 2011; Banks et al., 2020; Kumar et al., 2021).”
BackgroundGuedes, V. A., Mithani, S., Williams, C., Sass, D., Smith, E. G., Vorn, R., Wagner, C., Lai, C., Gill, J., & Hinson, H. E. (2022) · Neurotrauma Reports · doi:10.1089/neur.2022.0058 · Cited by 15
Amini, A., Shekari, F., Kashani, S. A., Eslami, N., Nazari, A., Tofigh, N., Shahpasand, K., Javar, H. A., & Baharvand, H. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114467 · Cited by 15
Shen, H., Chen, J., Liu, M., Zhao, M., Hu, D., Xie, F., Jin, Q., Xiao, D., Peng, Z., Qin, T., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1496304 · Cited by 23
Intranasal Delivery: Effects on the Neuroimmune Axes and Treatment of Neuroinflammation
Rhea, E. M., Logsdon, A. F., Banks, W. A., & Erickson, M. A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12111120 · Cited by 16
“Brain-to-blood efflux mechanisms can contribute to exosome distribution, and some proteins that efflux from brain such as tau andα-synuclein [164] are detectable in CNS-derived exosomes [161,165].”
BackgroundSelf-citationAibaidula, A., Fain, C. E., Garcia, L. M. C., Wier, A., Bouchal, S. M., Bauman, M. M. J., Jung, M. K., Sarkaria, J. N., Johnson, A. J., & Parney, I. F. (2023) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdad082 · Cited by 15
Do Bacterial Outer Membrane Vesicles Contribute to Chronic Inflammation in Parkinson’s Disease?
Koukoulis, T. F., Beauchamp, L. C., Kaparakis‐Liaskos, M., McQuade, R. M., Purnianto, A., Finkelstein, D. I., Barnham, K. J., & Vella, L. J. (2024) · Journal of Parkinson s Disease · doi:10.3233/jpd-230315 · Cited by 16
The Current Potential Pathogenesis of Amyotrophic Lateral Sclerosis
Jiang, S., & Xu, R. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04269-3 · Cited by 19
“EVs are able to cross the blood–brain barrier and thereby can enter and exit the CNS [112].”
Development of in vitro model of exosome transport in microfluidic gut-brain axis-on-a-chip
Seo, G. M., Lee, H., Kang, Y. J., Kim, D., & Sung, J. H. (2024) · Lab on a Chip · doi:10.1039/d4lc00490f · Cited by 15
Therapeutic potential of extracellular vesicles in neurodegenerative disorders
Roudi, S., Rädler, J., & Andaloussi, S. E. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-85555-6.00017-5 · Cited by 15
Importance of Extracellular Vesicle Derived RNAs as Critical Colorectal Cancer Biomarkers
Datta, B., Paul, D., Dey, T., Pal, S., & Rakshit, T. (2022) · ACS Bio & Med Chem Au · doi:10.1021/acsbiomedchemau.1c00043 · Cited by 15
Parsaei, H., Moosavifar, M., Eftekharzadeh, M., Ramezani, R., Barati, M., Mirzaei, S., & Nobakht, M. (2022) · Cell Biology International · doi:10.1002/cbin.11884 · Cited by 14
“These microscopic structures can cross the BBB and have the same functional properties as their parent cells (Banks et al., 2020; Elliott & He, 2021; Maqsood et al., 2020; Wei et al., 2020; Yin et al., 2019).”
BackgroundPfeiffer, P., Coates, J. R., Esqueda, Y. M., Kennedy, A., Getchell, K., McLenon, M., Kosa, E., & Aǵbaş, A. (2022) · Annals of Medicine · doi:10.1080/07853890.2022.2153162 · Cited by 14
Kodidela, S., Sinha, N., Kumar, A., Zhou, L., Godse, S., & Kumar, S. (2023) · Scientific Reports · doi:10.1038/s41598-023-29746-y · Cited by 14
Jakl, V., Popp, T., Haupt, J., Port, M., Roesler, R., Wiese, S., Friemert, B., Rojewski, M., & Schrezenmeier, H. (2023) · Cells · doi:10.3390/cells12162105 · Cited by 12
Pedrosa, M. A., Labandeira, C. M., Lago‐Baameiro, N., Valenzuela, R., Pardo, M., Labandeira-García, J. L., & Rodriguez-Perez, A. I. (2023) · Antioxidants · doi:10.3390/antiox12122045 · Cited by 14
“Interestingly, EVs can cross the blood–brain barrier (BBB) in a bi-directional manner [35,36].”
BackgroundResultExtracellular vesicles released from microglia after palmitate exposure impact brain function
de Paula, G. C., Aldana, B. I., Battistella, R., Fernández‐Calle, R., Bjure, A., Lundgaard, I., Deierborg, T., & Duarte, J. M. N. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03168-7 · Cited by 17
Elkomy, M. H., Hendawy, O. M., Zaki, R. M., Tulbah, A. S., Aldosari, B. N., Ali, A. A., & Eid, H. M. (2024) · Drug Delivery and Translational Research · doi:10.1007/s13346-024-01753-0 · Cited by 16
“PS is one of the critical factors that may affect how drugs are entrapped, released, and absorbed or penetrate cells via the BBB [44].”
Xu, F.-F., Liu, Z., Fang, X., Cao, B., Huang, Y., Peng, Y.-P., & Qiu, Y.-H. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114089 · Cited by 18
Whiteside, T. L. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-010376 · Cited by 13
“8 14 This provides a rationale for viewing TEX as potential anti-cancer vaccines.”
Self-citationPromoting exogenous repair in multiple sclerosis: myelin regeneration
Bezukladova, S., Genchi, A., Panina‐Bordignon, P., & Martino, G. (2022) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001062 · Cited by 16
“employed as therapeutic vehicles due to their capability to cross the BBB [27].”
BackgroundVaidya, M., Sreerama, S., Gonzalez-Vega, M. N., Smith, J., Field, M., & Sugaya, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043242 · Cited by 13
“Tumor cells can thus modify their own microenvironment via EVs [29,30].”
BackgroundPistono, C., Osera, C., Cuccia, M., & Bergamaschi, R. (2023) · Sclerosis · doi:10.3390/sclerosis1020011 · Cited by 13
MicroRNAs won the Nobel Prize. Now, can extracellular vesicles help them become drugs?
Li, V. Y., Rosas, N., Fleischer, S., Vunjak‐Novakovic, G., & Cheng, K. (2025) · Extracellular Vesicle · doi:10.1016/j.vesic.2025.100080 · Cited by 13
“42,43 A diverse array of loading techniques is advancing the use of EVs as carriers for therapeutic miRNAs, facilitating targeted gene silencing or activation through miRNA inhibitors and mimics.”
Titze-de-Almeida, S. S., Marina, C. L., Ramos, M. V., Silva, L. D. D. S., Brandão, P. R. D. P., Bispo, D. D. D. C., von Glehn, F., & Titze‐de‐Almeida, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178246 · Cited by 13
“…BBB is a semipermeable multicellular complex that selectively permits the transport of specific molecules based on their physicochemical characteristics through passive diffusion or active transport and is the main entry and exit route of exosomes from the circulatory system to the brain [107,108].”
Bukke, S. P. N., Yadav, S., Prajapati, S., Rani, S. S., Reddy, M. S., Thalluri, C., Chettupalli, A. K., Goruntla, N., Pradeepkumar, B., Eftekhari, Z., et al. (2025) · Tissue Barriers · doi:10.1080/21688370.2025.2607157 · Cited by 13
Transcytosis of tanycytes in the circumventricular organs of adult mouse brain
Okamoto, A., Fujii, R., YOSHIMURA, R., & Miyata, S. (2022) · Neuroscience Letters · doi:10.1016/j.neulet.2022.136633 · Cited by 14
Evolving insights into erythrocytes in synucleinopathies
Yang, Y., Nie, X., Wang, Y., Sun, J., Gao, X., & Zhang, J. (2024) · Trends in Neurosciences · doi:10.1016/j.tins.2024.06.005 · Cited by 15
Liu, Z., Cheng, L., Cao, W., Shen, C., Qiu, Y., Li, C., Xiong, Y., Yang, S., Chen, Z., Yin, X., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.135826 · Cited by 14
Brain–Periphery Axes: The Potential Role of Extracellular Vesicles-Delivered miRNAs
D’Amico, G., Carista, A., Manna, O. M., Paladino, L., Picone, D., Sarullo, S., Sausa, M., Cappello, F., Vitale, A. M., & Bavisotto, C. C. (2024) · Biology · doi:10.3390/biology13121056 · Cited by 19
Seki, I., Izumi, H., Okamoto, N., Ikenouchi, A., Morimoto, Y., Horie, S., & Yoshimura, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813902 · Cited by 13
“Although the relevant mechanisms are not yet fully understood, there is evidence that exosomes can pass through the BBB [42].”
BackgroundDenis, H. L., Jacquet, A. D. R., Alpaugh, M., Panisset, M., Barker, R. A., Boilard, É., & Cicchetti, F. (2025) · Fluids and Barriers of the CNS · doi:10.1186/s12987-025-00646-9 · Cited by 14
Unraveling the Bone–Brain Communication Network
Hansda, S., & Das, H. (2025) · Biology · doi:10.3390/biology14091279 · Cited by 15
“They also use specific ligand-receptor binding, are internalized into endocytic vesicles, and are then released into the brain parenchyma [62,64].”
Tumor exosomes impact functional hallmarks of cancer
Laein, M. H., Thinakaran, Y., Katoueezadeh, M., Iyappan, R., Baker, J., Kalailingam, P., Ngan, S. C., McCarthy, N. E., Klentrou, P., Tsiani, E., et al. (2026) · Cancer and Metastasis Reviews · doi:10.1007/s10555-026-10333-2 · Cited by 13
Inagaki, M., & Tachikawa, M. (2022) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c22-00072 · Cited by 10
Cummings, S. E., Delaney, S. P., Bissonnette, F. S.-D., Stalker, A., Muradia, G., Mehic, J., Graber, T. E., Alain, T., & Lavoie, J. R. (2023) · iScience · doi:10.1016/j.isci.2023.108708 · Cited by 11
Liu, J., Srivastava, S., Li, T., Moujane, F., Lee, J. Y., Chen, Y., Liu, H. H., Deng, S. X., & Xie, Y. (2025) · Biosensors · doi:10.3390/bios15030141 · Cited by 15
“SERS, on the other hand, as the improved methodology derived from Raman scattering, has solved this adverse flaw by amplifying the signal-to-noise ratio up to a factor of 10 14 .”
Almasi, F., Abbasloo, F., Soltani, N., Dehbozorgi, M., Fard, A. M., Kiani, A., Ghasemzadeh, N., Mesgari, H., Hosseingholi, E. Z., Payandeh, Z., et al. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04788-7 · Cited by 13
“Despite the innate capability of exosomes in crossing BBB, a large amount of externally administrated exosomes cannot reach the brain due to phagocytic immune cells being trapped in splenic or hepatic tissues [217].”
Zhang, S., Li, J., Hu, X., Liu, H., Yu, Q., Kuang, G., Liu, L., Yu, D., Lin, Z., & Xiong, N. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01262 · Cited by 20
“Given their ability to transport biomarkers and cross the blood– brain barrier (BBB), EVs have recently garnered considerable attention for their diagnostic and therapeutic potential in neurodegenerative diseases (Banks et al., 2020).”
Circulating Biomarkers for the Early Diagnosis of Alzheimer’s Disease
Nunkoo, V. S., Jurcău, A., Les, M., Cristian, A., Militaru, M., Marge, C., Iovanovici, D. C., & Jurcău, M. C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157268 · Cited by 15
“Being nanoscaled particles surrounded by a lipid bilayer [134], they can cross the blood–brain barrier [135], be harvested from the blood, and analyzed to obtain a molecular snapshot of the brain [136].”
Extracellular vesicles as a potential therapeutic for age-related macular degeneration
Chow, L. L. C., & Mead, B. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.367835 · Cited by 12
“Exosomes show supremacy over their parent cell due to various advantages such as quicker diffusive rate to target cells (Kastelowitz and Yin, 2014) and versatility of movement through the blood-brain/retinal barrier (Zagrean et al., 2018; Banks et al., 2020).”
BackgroundLaso-García, F., Fernandez, L. C., Piniella, D., Frutos, M. C. G.-D., Arizaga-Echebarria, J. K., Pérez‐Mato, M., Alonso‐López, E., Otero‐Ortega, L., Bravo, S. B., Chantada‐Vázquez, M. D. P., et al. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.03.006 · Cited by 11
Exploiting Nanomedicine for Cancer Polychemotherapy: Recent Advances and Clinical Applications
Boggio, E. M., Gigliotti, C. L., Stoppa, I., Pantham, D., Sacchetti, S., Rolla, R., Grattarola, M., Monge, C., Pizzimenti, S., Dianzani, U., et al. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030937 · Cited by 10
Role of Extracellular Vesicles in the Progression of Brain Tumors
Schiera, G., Liegro, C. M. D., Vento, F., & Liegro, I. D. (2024) · Biology · doi:10.3390/biology13080586 · Cited by 13
“Given the essential role that intercellular communication plays between tumor cells and the cells of the microenvironment, it is of fundamental importance to clarify the aforementioned questions; a better understanding of these relationships, and of the “tumor”
BackgroundCounil, H., Silva, R. O., Rabanel, J., Zaouter, C., Haddad, M., Khedher, M. R. B., Brambilla, D., Fülöp, T., Patten, S. A., & Ramassamy, C. (2025) · Journal of Extracellular Biology · doi:10.1002/jex2.70027 · Cited by 12
Mitochondria transfer for myelin repair
Mozafari, S., Peruzzotti-Jametti, L., & Pluchino, S. (2026) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x251325805 · Cited by 10
“146 Therefore, engineering methods have been employed to allow the modification of EVs or mitochondria to prolong their circulation in the blood, enhance brain uptake and their signaling action.”
Advancing Alzheimer’s disease therapy through engineered exosomal Macromolecules
Jain, S., Murmu, A., & Chauhan, A. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149590 · Cited by 11
Yang, L., Chan, M., Sheng, J., Qi, S., Chan, B., Shantaram, D., Rima, X. Y., Reátegui, E., Han, X., Hsueh, W. A., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70603 · Cited by 16
Bortoletto, A. S., & Parchem, R. J. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.369095 · Cited by 12
“However, despite the ability of exosomes to cross the blood-brain barrier and exacerbate neurodegeneration in the brain, further studies will be needed to determine the contribution of exosomal versus non-exosomal IAPP to the pathology of dementia (Banks et al., 2020).”
Lorenzis, E. D., Rindone, A., Donato, S. D., & Galdo, F. D. (2023) · Autoimmunity Reviews · doi:10.1016/j.autrev.2023.103401 · Cited by 11
Blundell, M., Doktor, F., Figueira, R. L., Khalaj, K., Biouss, G., Antounians, L., & Zani, A. (2023) · Pediatric Surgery International · doi:10.1007/s00383-023-05578-9 · Cited by 10
Plasma miR-203a-3p as a Novel Predictor of Dementia in Patients with Parkinson’s Disease
Hsu, Y.-F., Lin, S., Chu, Y., Tsai, Y., Huang, J., Phoa, F. K. H., & Wu, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063554 · Cited by 11
“Circulating miRNAs consist of different fractions of miRNAs [19] and may be contained within the extracellular vesicles and be transported across the blood–brain barrier (BBB) [20].”
BackgroundExtracellular Vesicles and Their Interplay with Biological Membranes
Yeo Xian Ping, J., Raj Neupane, Y., & Pastorin, G. (2022) · Physiology · doi:10.5772/intechopen.101297 · Cited by 9
Whiteside, T. L. (2023) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2023.2178902 · Cited by 10
“However, circulating TEX can readily access immune cells in distantly located tissues as recently reported [1,2].”
BackgroundSelf-citationTherapeutic Potential of Extracellular Vesicles in Oral Inflammation
Farm, Y. R., Chuah, B. H., Law, J. X., Leong, X.-F., Razali, M., & Ng, S. L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073031 · Cited by 10
“For instance, it was demonstrated that multiple exosome populations can cross the blood–brain barrier (BBB), with influx rates ranging from 0.044 to 0.524 µ L/g-min, highlighting their ability to move from the bloodstream into the brain parenchyma via transcytotic pathways [82].”
InfluentialRosso, G., van Veen, S., Sancho‐Albero, M., Tamboia, G., Empereur‐mot, C., Perego, C., Kuipers, M. E., Dumontel, B., Ajó, A., Hoen, E. N. M. N., et al. (2025) · ACS Applied Nano Materials · doi:10.1021/acsanm.5c01459 · Cited by 12
Grahl, M. V. C., Andrade, B. D. S., Perin, A. P. A., Neves, G. A., Duarte, L. D. S., Uberti, A. F., Hohl, K. S., Follmer, C., & Carlini, C. R. (2023) · Microorganisms · doi:10.3390/microorganisms11082042 · Cited by 15
“These vesicles can cross the BBB and deliver their protein cargo into the CNS [159,160], serving as carriers to shuttle the ureases produced by H. pylori or P. mirabilis into the brain.”
BackgroundInfluentialCarr, K. D., Weiner, S. P., Vásquez, C., & Schmidt, A. M. (2023) · Physiology & Behavior · doi:10.1016/j.physbeh.2023.114337 · Cited by 12
Engineered exosomes derived from stem cells: a new brain-targeted strategy
Waqas, A., Huang, S., & Chen, L. (2024) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2024.2306877 · Cited by 9
“However, the mechanisms by which derived exosomes migrate from the peripheral circulation to the brain have yet to be entirely understood [134,135].”
BackgroundToll-like receptor 7: A novel neuroimmune target to reduce excessive alcohol consumption
Allard, R. L., Mayfield, J., Barchiesi, R., Salem, N. A., & Mayfield, R. D. (2024) · Neurobiology of Stress · doi:10.1016/j.ynstr.2024.100639 · Cited by 11
“EVs can cross the BBB through various mechanisms (Banks et al., 2020), and cellular communication through EVs is critical for maintaining homeostasis.”
BackgroundVaidya, M., Sreerama, S., Gaviria, M., & Sugaya, K. (2022) · Journal of Nucleic Acids · doi:10.1155/2022/7960198 · Cited by 9
“They can cross the blood-brain barrier (BBB) and anatomical compartments by transcytosis to be detected in peripheral blood and other body fluids (2).”
BackgroundTherapeutic and diagnostic potential of extracellular vesicles in amyotrophic lateral sclerosis
Ellison, T. J., Stice, S. L., & Yao, Y. (2022) · Extracellular Vesicle · doi:10.1016/j.vesic.2022.100019 · Cited by 8
Mazahir, F., Alam, M. I., & Yadav, A. K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102318 · Cited by 10
Cai, Y., Li, Q., Wesselmann, U., & Zhao, C. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202406876 · Cited by 9
Abdi, S. M. Y., Bakri, S. S. M. A., & Nordin, N. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01598-x · Cited by 8
“…formation of endocytic vesicles from the plasma membrane, (2) the inward budding of the endosomal vesicle membrane, resulting in MVBs composed of intraluminal vesicles (ILVs), and (3) the fusion of these MVBs with the plasma membrane, which releases the vesicular contents, known as exosomes [12].”
Lee, Y., Mohamed, R. W., & Yang, S. (2025) · Pharmaceuticals · doi:10.3390/ph18040458 · Cited by 13
Metadata
- Authors
- Banks, W. A., Sharma, P., Bullock, K. M., Hansen, K. M., Ludwig, N., & Whiteside, T. L.
- Affiliations
- University of Washington (US)
- University of Pittsburgh (US)
- Corresponding author
- Banks, William A.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-06-21
- Volume
- 21
- Issue
- 12
- Pages
- 4407
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7352415
- OpenAlex
- W3036596408
- Cited by
- 561
- References
- 57
- Citations by year
- 2026: 99 · 2025: 102 · 2024: 132 · 2023: 90 · 2022: 81 · 2021: 54 · 2020: 2
- FWCI
- 18.72
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Institutes of Health (1RO1 AG046619)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- extracellular vesicles, exosomes, blood-brain barrier, BBB crossing, brain pharmacokinetics, lipopolysaccharide, inflammation, mannose 6-phosphate receptor, CD46, integrins, ICAM-1, vesicular transporters
- MeSH terms
- Animals, Biological Transport, Blood-Brain Barrier, Cell Line, Humans, Inflammation, Male, Cell Line, Tumor, Mice, Exosomes, Transcytosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.